Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Int J Mol Sci ; 24(3)2023 Jan 19.
Artigo em Inglês | MEDLINE | ID: mdl-36768324

RESUMO

Blue whiting (BW) represents an underutilised fish species containing a high-quality protein and amino acid (AA) profile with numerous potentially bioactive peptide sequences, making BW an economic and sustainable alternative source of protein. This study investigated the impact of three different BW protein hydrolysates (BWPH-X, Y and Z) on growth, proliferation and muscle protein synthesis (MPS) in skeletal muscle (C2C12) myotubes. BWPHs were hydrolysed using different enzymatic and heat exposures and underwent simulated gastrointestinal digestion (SGID), each resulting in a high degree of hydrolysis (33.41-37.29%) and high quantities of low molecular mass peptides (86.17-97.12% <1 kDa). C2C12 myotubes were treated with 1 mg protein equivalent/mL of SGID-BWPHs for 4 h. Muscle growth and myotube thickness were analysed using an xCelligence™ platform. Anabolic signalling (phosphorylation of mTOR, rpS6 and 4E-BP1) and MPS measured by puromycin incorporation were assessed using immunoblotting. BWPH-X significantly increased muscle growth (p < 0.01) and myotube thickness (p < 0.0001) compared to the negative control (amino acid and serum free media). Muscle protein synthesis (MPS), as measured by puromycin incorporation, was significantly higher after incubation with BWPH-X compared with the negative control, but did not significantly change in response to BWPH-Y and Z treatments. Taken together, these preliminary findings demonstrate the anabolic potential of some but not all BWPHs on muscle enhancement, thus providing justification for human dietary intervention studies to confirm and translate the results of such investigations to dietary recommendations and practices.


Assuntos
Proteínas Alimentares , Gadiformes , Músculo Esquelético , Hidrolisados de Proteína , Animais , Humanos , Aminoácidos/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Hidrolisados de Proteína/metabolismo , Puromicina , Proteínas Alimentares/metabolismo , Gadiformes/metabolismo
2.
J Sci Food Agric ; 95(7): 1514-20, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25082083

RESUMO

BACKGROUND: Dietary mineral deficiency, hypertension and diabetes have become serious human health problems. Dietary approaches are increasingly being investigated to address these issues. Identification of food-derived biological peptides has become an important approach to control such diseases. Peptides generated from aquatic byproducts have been shown to possess biological activities. RESULTS: Significantly higher copper-chelating activity was observed on simulated hydrolysis of intact collagen. The collagen hydrolysate generated in the gastric stage exhibited moderate angiotensin-converting enzyme (ACE)-inhibitory activity with an IC50 value of 2.92 ± 0.22 mg mL(-1), which significantly decreased to 0.49 ± 0.02 mg mL(-1) after intestinal digestion. The dipeptidyl peptidase (DPP) IV-inhibitory potency of the collagen hydrolysate generated directly following simulated gastrointestinal digestion (SGID) (IC50 2.59 ± 0.04 mg mL(-1)) was significantly lower than that of the collagen tryptic hydrolysate (CTH) (IC50 1.53 ± 0.01 mg mL(-1)). The antioxidant activities of collagen and CTH using the ferric-reducing antioxidant power (FRAP) assay were 0.87 ± 0.10 and 1.27 ± 0.03 µmol Trolox equivalent (TE) g(-1) respectively after SGID. CONCLUSION: This study identifies collagen as a good and inexpensive substrate for the generation of biologically active peptides with potential applications as functional ingredients in the management of chronic illness and mineral deficiency problems.


Assuntos
Colágeno/farmacologia , Proteínas Alimentares/farmacologia , Gadiformes , Peptídeos/farmacologia , Hidrolisados de Proteína/farmacologia , Alimentos Marinhos , Pele/química , Inibidores da Enzima Conversora de Angiotensina/metabolismo , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Animais , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Quelantes/metabolismo , Quelantes/farmacologia , Colágeno/metabolismo , Proteínas Alimentares/metabolismo , Digestão , Inibidores da Dipeptidil Peptidase IV/metabolismo , Inibidores da Dipeptidil Peptidase IV/farmacologia , Proteínas de Peixes/metabolismo , Proteínas de Peixes/farmacologia , Humanos , Mucosa Intestinal/metabolismo , Peptídeos/metabolismo , Hidrolisados de Proteína/metabolismo
3.
J Sci Food Agric ; 94(7): 1373-9, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24114648

RESUMO

BACKGROUND: Large quantities of brewers' spent grain (BSG), a co-product of the brewing industry, are produced annually. BSG contains hydroxycinnamic acids, and phenolic-rich extracts from BSG have previously demonstrated the ability to protect against oxidant-induced DNA damage. The present study investigated the anti-inflammatory potential of eight phenolic extracts from BSG: four pale (P1-P4) and four black (B1-B4) extracts. RESULTS: BSG extracts were more cytotoxic in Jurkat T than U937 cells, with lower IC50 values in Jurkat T cells, measured using the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Pale BSG extracts P2 and P3 showed the greatest anti-inflammatory potential, significantly (P < 0.05) reducing interleukin-2 (IL-2), interleukin-4 (IL-4, P2 only), interleukin-10 (IL-10) and interferon-γ (IFN-γ) production. In addition, extracts P1-P3 and B2-B4 showed significant (P < 0.05) antioxidant effects, determined by the cellular antioxidant activity assays superoxide dismutase, catalase and glutathione content (GSH). CONCLUSION: Phenolic extracts from BSG, particularly the pale BSG extracts, have the ability to reduce a stimulated cytokine production and may also protect against cellular oxidative stress. Results of the present study highlight the potential of BSG phenolic extracts to act as functional food ingredients, providing an alternative use and improving the value of this brewing industry co-product.


Assuntos
Antioxidantes/metabolismo , Cerveja , Ácidos Cumáricos/metabolismo , Grão Comestível/química , Fatores Imunológicos/metabolismo , Resíduos Industriais/análise , Fenóis/metabolismo , Anti-Inflamatórios não Esteroides/análise , Anti-Inflamatórios não Esteroides/economia , Anti-Inflamatórios não Esteroides/isolamento & purificação , Anti-Inflamatórios não Esteroides/metabolismo , Antineoplásicos Fitogênicos/análise , Antineoplásicos Fitogênicos/economia , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/metabolismo , Antioxidantes/análise , Antioxidantes/economia , Antioxidantes/isolamento & purificação , Cerveja/economia , Cerveja/microbiologia , Linhagem Celular Tumoral , Ácidos Cumáricos/análise , Ácidos Cumáricos/economia , Ácidos Cumáricos/isolamento & purificação , Citocinas/antagonistas & inibidores , Citocinas/metabolismo , Grão Comestível/economia , Alimentos Fortificados/análise , Alimentos Fortificados/economia , Indústria de Processamento de Alimentos/economia , Humanos , Fatores Imunológicos/análise , Fatores Imunológicos/economia , Fatores Imunológicos/isolamento & purificação , Resíduos Industriais/economia , Irlanda , Leucemia de Células T/imunologia , Leucemia de Células T/metabolismo , Monócitos/enzimologia , Monócitos/imunologia , Monócitos/metabolismo , Fenóis/análise , Fenóis/economia , Fenóis/isolamento & purificação , Pigmentação , Extratos Vegetais/química , Extratos Vegetais/economia , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/metabolismo , Reciclagem
4.
Food Chem ; 134(2): 641-6, 2012 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-23107673

RESUMO

Brewers' spent grain (BSG), a by-product of the brewing industry, contains high amounts of phenolic acids, which have antioxidant effects. The present study examined the ability of BSG extracts to protect against the genotoxic effects of oxidants, hydrogen peroxide (H(2)O(2)), 3-morpholinosydnonimine hydrochloride (SIN-1), 4-nitroquinoline 1-oxide (4-NQO) and tert-butylhydroperoxide (t-BOOH) in U937 cells. Four pale (P1-P4) and four black (B1-B4) BSG extracts were investigated. U937 cells were pre-incubated with BSG extracts, exposed to the oxidants and the DNA damage was measured by the Comet assay. The black BSG extracts (B1-B4) significantly protected against H(2)O(2)-induced DNA damage. Extract B2, which had the highest phenol content, provided the greatest protection. Extracts P2, B2, B3 and B4 provided significant protection against SIN-1-induced DNA damage. None of the extracts protected against DNA damage induced by t-BOOH and 4-NQO. The DNA protective effects of the BSG phenolic extracts may be related to iron chelation.


Assuntos
Antioxidantes/farmacologia , Quebras de DNA de Cadeia Simples/efeitos dos fármacos , Dano ao DNA/efeitos dos fármacos , Grão Comestível/química , Peróxido de Hidrogênio/toxicidade , Resíduos Industriais/análise , Oxidantes/toxicidade , Fenóis/farmacologia , Extratos Vegetais/farmacologia , Substâncias Protetoras/farmacologia , Humanos , Células U937
5.
Br J Clin Pharmacol ; 67(6): 592-8, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19594525

RESUMO

Here we discuss 15 recommendations for reducing the risks of medication errors: 1. Provision of sufficient undergraduate learning opportunities to make medical students safe prescribers. 2. Provision of opportunities for students to practise skills that help to reduce errors. 3. Education of students about common types of medication errors and how to avoid them. 4. Education of prescribers in taking accurate drug histories. 5. Assessment in medical schools of prescribing knowledge and skills and demonstration that newly qualified doctors are safe prescribers. 6. European harmonization of prescribing and safety recommendations and regulatory measures, with regular feedback about rational drug use. 7. Comprehensive assessment of elderly patients for declining function. 8. Exploration of low-dose regimens for elderly patients and preparation of special formulations as required. 9. Training for all health-care professionals in drug use, adverse effects, and medication errors in elderly people. 10. More involvement of pharmacists in clinical practice. 11. Introduction of integrated prescription forms and national implementation in individual countries. 12. Development of better monitoring systems for detecting medication errors, based on classification and analysis of spontaneous reports of previous reactions, and for investigating the possible role of medication errors when patients die. 13. Use of IT systems, when available, to provide methods of avoiding medication errors; standardization, proper evaluation, and certification of clinical information systems. 14. Nonjudgmental communication with patients about their concerns and elicitation of symptoms that they perceive to be adverse drug reactions. 15. Avoidance of defensive reactions if patients mention symptoms resulting from medication errors.


Assuntos
Monitoramento de Medicamentos , Prescrições de Medicamentos/normas , Educação Médica/organização & administração , Anamnese/normas , Erros de Medicação/prevenção & controle , Gestão de Riscos/organização & administração , Monitoramento de Medicamentos/normas , Educação Médica/normas , Humanos , Relações Interprofissionais , Relações Profissional-Paciente , Gestão de Riscos/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA